Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington’s disease
Qian Ma, Jianmin Yang, Teresa A. Milner, Jean-Paul G. Vonsattel, Mary Ellen Palko, Lino Tessarollo, Barbara L. Hempstead
Qian Ma, Jianmin Yang, Teresa A. Milner, Jean-Paul G. Vonsattel, Mary Ellen Palko, Lino Tessarollo, Barbara L. Hempstead
View: Text | PDF
Research Article Neuroscience

SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington’s disease

  • Text
  • PDF
Abstract

Motor dysfunction is a prominent and disabling feature of Huntington’s disease (HD), but the molecular mechanisms that dictate its onset and progression are unknown. The N-methyl-D-aspartate receptor 2A (NR2A) subunit regulates motor skill development and synaptic plasticity in medium spiny neurons (MSNs) of the striatum, cells that are most severely impacted by HD. Here, we document reduced NR2A receptor subunits on the dendritic membranes and at the synapses of MSNs in zQ175 mice that model HD. We identify that SorCS2, a vacuolar protein sorting 10 protein–domain (VPS10P-domain) receptor, interacts with VPS35, a core component of retromer, thereby regulating surface trafficking of NR2A in MSNs. In the zQ175 striatum, SorCS2 is markedly decreased in an age- and allele-dependent manner. Notably, SorCS2 selectively interacts with mutant huntingtin (mtHTT), but not WT huntingtin (wtHTT), and is mislocalized to perinuclear clusters in striatal neurons of human HD patients and zQ175 mice. Genetic deficiency of SorCS2 accelerates the onset and exacerbates the motor coordination deficit of zQ175 mice. Together, our results identify SorCS2 as an interacting protein of mtHTT and demonstrate that impaired SorCS2-mediated NR2A subunit trafficking to dendritic surface of MSNs is, to our knowledge, a novel mechanism contributing to motor coordination deficits of HD.

Authors

Qian Ma, Jianmin Yang, Teresa A. Milner, Jean-Paul G. Vonsattel, Mary Ellen Palko, Lino Tessarollo, Barbara L. Hempstead

×

Figure 2

SorCS2 is expressed in medium spiny neurons of mouse striatum and interacts with NR2A in striatal lysates.

Options: View larger image (or click on image) Download as PowerPoint
SorCS2 is expressed in medium spiny neurons of mouse striatum and intera...
(A) Immunofluorescence staining in adult mouse striatum using antibodies against SorCS2 (red) and Darpp-32 (green), a marker for medium spiny neurons. Immunolabeling of SorCS2 exhibits punctate staining pattern in the soma of Darpp-3–labeled neurons in WT striatum (left panel). SorCS2 immunoreactivity is absent in SorCS2–/– striatum (right panel). n = 3 animals/genotype; scale bar: 10 μm. (B) Co-IP of NR2A with SorCS2 in adult mouse striatal lysate using antibodies against SorCS2. KO, SorCS2–/–. (C) Co-IP of SorCS2 with NR2A in adult mouse striatal lysate using antibodies against NR2A. Ab, rabbit antibody against NR2A used in IP; IgG, rabbit IgG used in IP as a negative control. (D) Co-IP of VPS35 with SorCS2 in adult WT mouse striatal lysate using antibody against SorCS2. The same experiments were also run in parallel using SorCS2–/– (KO) tissue as a negative control for antibody specificity. (B–D) Three independent experiments were conducted.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts